HIV prevention news: Europe

From 2012 to 2016, NAM published a monthly bulletin that covered HIV prevention news and research in Europe, and of relevance to Europe. It aimed to strengthen knowledge of new prevention options and share the latest HIV prevention news and research.

In that period, HIV prevention evolved rapidly, with landmark research developments in new prevention technologies and approaches, including HIV treatment as prevention (TasP), pre-exposure prophylaxis (PrEP), expanded testing programmes and advocacy for proven approaches that remain unprovided, such as syringe and needle exchange and condoms in prisons.

An archive of the bulletin is available in English, Spanish, Portuguese, French and Russian.

Archive

Issue #24 - December 2014

  • Two European PrEP trials report high effectiveness
  • Progress on HIV vaccines: new human trials by 2016?
  • UNAIDS: We can end HIV, but only if we treat nearly everyone
  • What could stop treatment working as prevention?
  • Europe “is falling behind” in its HIV response
  • Injectable PrEP drug might work better for men than women
  • Other recent news headlines
  • Editors' picks from other sources
  • Survey: HIV dialogue
  • HIV prevention bulletin
  • Acknowledgements

Issue #23 - October 2014

  • European study shows that less education is associated with late diagnosis and treatment
  • PrEP will need high adherence, high effectiveness and high coverage in high-risk populations to be affordable
  • Learning about additional HIV prevention methods doesn’t undermine gay men’s intentions to use condoms
  • Expanded harm reduction in Scotland achieves impressive drop in hepatitis C among people who inject drugs
  • Novel immune-suppressant vaccine completely blocks HIV infection in monkeys: human trials planned
  • HIV testing rates are improving in African people in England
  • Gay men in London getting younger at diagnosis
  • Other recent news headlines
  • Editors' picks from other sources
  • Survey: HIV prevention and apps
  • HIV prevention bulletin
  • Acknowledgements

Issue #22 - September 2014

  • Melbourne special – news from the 20th International AIDS Conference
  • A tale of two cities: why is HIV incidence in gay men falling in San Francisco but not in London?
  • New HIV in people who use drugs in Europe is related to economic decline: can be contained with good programmes
  • Fifty per cent efficacy in open-label PrEP study, but 100% with adequate adherence
  • Doing it together: couple counselling may be a vital component of HIV prevention in Africa
  • Nearly one in five gay men in eastern Europe has been arrested for being gay – only one in fifty in western Europe
  • Sex workers need support for condom use with regular partners
  • Other news headlines from Melbourne
  • Of guidelines, targets and resources
  • AIDS 2014
  • European HIV testing and counselling survey
  • Community survey on migrant access to health services
  • HIV prevention bulletin
  • Acknowledgements

Issue #21 - July 2014

  • European community prevention advocates prioritise testing; increased interest in treatment as prevention
  • Gay men who discuss HIV status with sexual partners are less likely to acquire HIV
  • High proportion of ‘heterosexual’ men with HIV probably got it from other men
  • European CDC cautious about PrEP
  • Signs of new needle-led HIV epidemic in Middle East and North Africa
  • High levels of adherence to study medication among women who conceived during HIV PrEP study
  • Drug-resistant gonorrhoea rates plummet in US and UK
  • Other recent news headlines
  • AIDS 2014
  • European HIV testing and counselling survey
  • Community survey on migrant access to health services
  • HIV prevention bulletin
  • Acknowledgements
  • Editors' picks from other sources

Issue #20 - June 2014

  • US public health department recommends PrEP
  • Impossible to rule out risk of infection from someone on treatment
  • HIV infection on PrEP will probably not cause drug resistance
  • STI diagnoses much higher in people not taking HIV treatment
  • Tenofovir as PrEP causes no long-term harm to kidneys
  • Other recent news headlines
  • Community survey on migrant access to health services
  • Community consensus statement
  • HIV prevention bulletin
  • Acknowledgements
  • Editors' picks from other sources

Issue #19 - May 2014

  • UK PrEP study completes enrolment
  • Expanded HIV testing may find more acute infections as well as late ones
  • 'Chemsex' not common in London gay men; more so in men with HIV
  • HIV diagnoses in French gay men up 14%, mainly due to more testing
  • HIV genital viral load: undetectable in women on treatment, can vary hourly in men
  • Taiwan harm reduction programme cuts HIV in drug users by 80%
  • Rwanda cuts HIV incidence by 90% as it goes for universal HIV treatment
  • Other recent news headlines
  • Community survey on migrant access to health services
  • Community consensus statement
  • HIV prevention bulletin
  • Acknowledgements
  • Editors' picks from other sources

Issue #18 - March 2014

  • No-one with an undetectable viral load transmits HIV in two years of study
  • STIs greatly increase risk of acquiring HIV in pregnancy
  • Very different levels of PrEP uptake and adherence in three US cities
  • Not having sex with serodiscordant partners is HIV prevention strategy for 40% of gay men
  • One-in-ten HIV-positive gay men report using viral load to decide on condom use
  • More HIV testing and treatment on diagnosis needed to curtail UK gay epidemic
  • NAM/AVAC webinar: the prevention needs of people who use drugs in Europe
  • Other recent news headlines
  • Editors' picks from other sources
  • Community consensus statement
  • HIV prevention bulletin
  • Acknowledgements

Issue #17 - February 2014

  • Home testing
  • Risk factors for LGV identified
  • Gay men’s mental health
  • Attrition in the treatment cascade
  • The limits of individual responsibility
  • Online press conference: HIV treatment as prevention community consensus statement
  • Other recent news headlines
  • HIV treatment as prevention – launch of community consensus statement
  • HIV prevention bulletin
  • Acknowledgements
  • Editors' picks from other sources

Issue #16 - January 2014

  • Gay men run very different risks of HIV; implications for PrEP
  • Big reduction in drug injecting in people who test positive for hepatitis C
  • English study looks at male sex workers
  • Young newly diagnosed gay men in US have high viral loads
  • Testing on hospital admission picks up many new diagnoses
  • Computerised counselling achieves reductions in viral load and risk behaviour
  • NAM/AVAC webinar – HIV prevention research update: what to watch in 2014
  • Other recent news headlines
  • Webinar: what to watch in 2014
  • HIV prevention bulletin
  • Acknowledgements
  • Editors' picks from other sources

This project has been supported via a grant from Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare.

Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare have provided funding for this project and have had no editorial control over the content of the materials.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.